​

​

PLL-g-PEG inhibits antibody-drug conjugate uptake into human corneal epithelial cells in vitro.

​

PLL-g-PEG eye drops in chronic dry eye patients: results from a one-month clinical trial including a controlled adverse environment chamber

​

Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops.

​

Dry Eye Syndrome: A Review & Novel Formulation Approach.

​